Association between the FMR1 CGG repeat lengths and the severity of idiopathic primary ovarian insufficiency: a meta analysis
Source abstract
Abstract
Aim Reports on the association of the CGG repeat length in the FMR1 gene with the severity of idiopathic POI are inconclusive. Therefore, a meta analysis was performed to investigate the relationship between the expansion of repeat CGG and idiopathic POI risk.Methods Up to January 2019, 18 case-control or cohort studies involving 3022 idiopathic POI patients and 8461 controls were included for meta analysis.Results Thirteen studies, including 2047 cases and 6912 controls, met our criteria for the assessment of the premutation and intermediate repeat length in patients patients with POI. Compared with controls, FMR1 gene premutation is significantly associated with POI (OR = 8.13; 95% CI: 4.35–15.19; p < .00001), whereas there was no significant correlation between intermediate repeat length and POI (OR = 0.86; 95% CI: 0.62–1.18; p = .34). Six studies, representing 975 patients and 1749 controls, were eligible for evaluation of the premutation and intermediate repeat length in diminished ovarian reserve (DOR). The association between premutation and DOR was significant (OR=14.87; 95% CI:5.20-42.52; p < 0.00001), while no significant correlation of intermediate size to DOR was found in the case-control comparison (OR = 0.98; 95% CI: 0.65–1.47; p = 0.93).Conclusion There is a close association between premutation of the FMR1 gene and increased susceptibility to idiopathic POI of each stage and no correlation between intermediate repeat length of the FMR1 gene and the severity of idiopathic POI.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Genetics and Neurodevelopmental Disorders · Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities · Genomic variations and chromosomal abnormalities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Reproductive Medicine Center, Clinical College of People’s Liberation Army, Anhui Medical University
Reproductive Medicine Center, the 901th Hospital of the Joint Logistics Support Force of People’s Liberation Army
Reproductive Medicine Center, Department of Obstetrics and Gynecology, the First Affiliated Hospital of Anhui Medical University
Funding
National Natural Science Foundation of China · Anhui Province Natural Science Foundation
References (39)
Show source-provided references
1. 10.1056/NEJMcp080869710.1056/NEJMcp0808697 ↗
2. 10.1111/j.1365-2265.2007.03073.x10.1111/j.1365-2265.2007.03073.x ↗
3. 10.1016/S0140-6736(10)60355-810.1016/S0140-6736(10)60355-8 ↗
4. 10.1055/s-0031-128091510.1055/s-0031-1280915 ↗
5. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–606.
6. 10.1093/humupd/dmi01210.1093/humupd/dmi012 ↗
7. 10.1093/humrep/14.10.245510.1093/humrep/14.10.2455 ↗
8. 10.1093/humupd/dmv03610.1093/humupd/dmv036 ↗
9. 10.1016/j.fertnstert.2006.09.00410.1016/j.fertnstert.2006.09.004 ↗
10. 10.1097/gme.0b013e318164776210.1097/gme.0b013e3181647762 ↗
11. 10.1093/humrep/dem14810.1093/humrep/dem148 ↗
12. 10.1097/GIM.0b013e31821705e510.1097/GIM.0b013e31821705e5 ↗
13. 10.1093/humrep/dei43210.1093/humrep/dei432 ↗
14. 10.1007/s00439-005-1326-810.1007/s00439-005-1326-8 ↗
15. 10.1016/j.fertnstert.2008.07.00710.1016/j.fertnstert.2008.07.007 ↗
16. 10.1093/humrep/deq05810.1093/humrep/deq058 ↗
17. 10.1016/j.fertnstert.2011.08.02810.1016/j.fertnstert.2011.08.028 ↗
18. 10.1016/j.fertnstert.2016.09.03210.1016/j.fertnstert.2016.09.032 ↗
19. Eslami A, Farahmand K, Totonchi M, et al. FMR1 premutation: not only important in premature ovarian failure but also in diminished ovarian reserve. Human Fertil. 2016;20:1–6.
20. 10.1016/j.gene.2013.03.03210.1016/j.gene.2013.03.032 ↗
21. 10.1038/gim.2013.14610.1038/gim.2013.146 ↗
22. 10.1038/gim.2013.6410.1038/gim.2013.64 ↗
23. 10.1016/S1472-6483(10)60086-710.1016/S1472-6483(10)60086-7 ↗
24. 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B ↗
25. 10.1002/(SICI)1096-8628(19990528)84:3<300::AID-AJMG27>3.0.CO;2-510.1002/(SICI)1096-8628(19990528)84:3<300::AID-AJMG27>3.0.CO;2-5 ↗
26. 10.1016/S1472-6483(10)60173-310.1016/S1472-6483(10)60173-3 ↗
27. Lin L, Yu D, Du X, et al. Research of FMR1 gene CGG repeat polymorphism with premature ovarian failure. J Hebei Med Univ. 2013;34:1031–1034.
28. 10.1016/j.rbmo.2014.05.00410.1016/j.rbmo.2014.05.004 ↗
29. 10.1371/journal.pone.010331610.1371/journal.pone.0103316 ↗
30. 10.1177/193371911244607410.1177/1933719112446074 ↗
31. 10.1016/j.gene.2018.07.03410.1016/j.gene.2018.07.034 ↗
32. 10.3390/genes808019410.3390/genes8080194 ↗
33. 10.1093/humrep/der16810.1093/humrep/der168 ↗
34. 10.1097/01.GIM.0000182468.22666.dd10.1097/01.GIM.0000182468.22666.dd ↗
35. 10.1016/0092-8674(95)90275-910.1016/0092-8674(95)90275-9 ↗
36. 10.1016/j.fertnstert.2006.05.07910.1016/j.fertnstert.2006.05.079 ↗
37. Weiss K, Orr-Urtreger A, Kaplan Ber I, et al. Ethnic effect on FMR1 carrier rate and AGG repeat interruptions among Ashkenazi women. Gen Med. 2014;16:940–944.
38. 10.1266/ggs.88.21110.1266/ggs.88.211 ↗
39. 10.1002/ajmg.1042710.1002/ajmg.10427 ↗